[ad_1]
The Food and Drug Administration is further expanding its recall of widely prescribed antihypertensive medications due to contamination by a cancer-related chemical.
Monday's announcement targets five other batches of the losartan generic drug manufactured by Torrent Pharmaceuticals Limited. The batches include losartan potassium tablets and losartan potassium / hydrochlorothiazide tablets.
The recalled batches contain traces of N-methylnitrosobutyric acid, or NMBA, which have been linked to cancer.
This is the fifth time in 2019 that Torrent Pharmaceuticals is expanding its voluntary recall of losartan. The recall was announced for the first time in January.
Losartan is a generic blocker of angiotensin II receptors, or ARA, which is used to treat high blood pressure, as well as heart failure. Over the last year, dozens of generic ARA lots have been pulled off the market due to the presence of chemical contaminants called nitrosamines, which have been associated with an increased risk of certain types of cancer.
[ad_2]
Source link